SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000895813-21-000015
Filing Date
2021-11-17
Accepted
2021-11-17 09:46:10
Documents
1
Period of Report
2020-12-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 6346
  Complete submission text file 0000895813-21-000015.txt   7735
Mailing Address 7982 DOUG HILL SAN DIEGO CA 92127
Business Address
Hopper Paul (Reporting) CIK: 0001355220 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39788 | Film No.: 211418732

Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Issuer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations